Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Real-world Effectiveness of a Combined Group-individual Schema Therapy for Borderline Personality Disorder: A Pragmatic Randomized Clinical Trial

NCT04211688 is registered in ClinicalTrials.gov with Consorci Sanitari del Maresme as lead sponsor.

NCT NCT04211688
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04211688 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Real-world Effectiveness of a Combined Group-individual Schema Therapy for Borderline Personality Disorder: A Pragmatic Randomized Clinical Trial
Lead sponsor
Consorci Sanitari del Maresme
Phase
Not applicable
Overall status
Completed
Start date
January 12, 2017
Completion date
December 1, 2019
Enrollment
80 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

borderline personality disorder, randomized controlled trial